Abstract
High c-MET expression defines a subset of pancreatic adenocarcinoma patients with poor prognosis following surgical resection: Exploration of mechanisms driving c-MET overexpression, transcriptomic analyses, and in vitro effects of c-MET inhibitors
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
